TABLE 2.
Clinical, serological, therapeutic, and culture data for eight Q fever patients with blood cultures positive for C. burnetii
| Patient no. | Diagnosis at admission (duration of fever [days]) | Treatment | Phase II antibody titer for:
|
Blood culture (day)c | ||
|---|---|---|---|---|---|---|
| IgM | IgG | IgA | ||||
| CB1 | Fevera (10) | Vibramycin | 3,200 | 3,840 | 200 | + (10) |
| CB2 | Pneumoniab + fever (8) | Vibramycin | 800 | 7,680 | 800 | + (12) |
| CB3 | Pneumonia + fever (6) | Vibramycin | 6,400 | 30,700 | 6,900 | + (11) |
| CB4 | Pneumonia + fever (9) | Macrolide | 51,200 | 61,440 | 12,800 | + (8) |
| CB5 | Pneumonia + fever (10) | Macrolide | 102,400 | 122,880 | 200 | + (6) |
| CB6 | Pneumonia + fever (6) | Macrolide | 3,200 | 7,680 | 800 | + (10) |
| CB7 | Pneumonia + fever (8) | Vibramycin | 6,400 | 30,720 | 12,800 | + (8) |
| CB8 | Pneumonia + fever (5) | Macrolide | 800 | 3,840 | 200 | + (12) |
a
Body temperature greater than or equal to 38°C.
b
Dyspnea, cough, expectoration, hemoptysis, or chest pain associated with chest radiographic abnormalities.
c
+, positive shell vial cultures.